Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL96P is a processed pseudogene of the 7SL RNA gene family, specifically designated as "RNA, 7SL, cytoplasmic 96, pseudogene". Unlike its parent gene, which encodes the functional RNA component of the signal recognition particle (SRP) involved in protein targeting to the endoplasmic reticulum, RN7SL96P does not produce a functional protein or RNA[3][2]. Pseudogenes like RN7SL96P are genomic elements with high sequence similarity to functional genes but typically lack coding potential or critical regulatory signals required for protein or structural RNA production[2]. Although most pseudogenes are considered non-functional, some have been shown to be transcribed and may generate small non-coding RNAs that modulate gene expression or participate in chromatin regulation. The functional relevance of RN7SL96P specifically has not been established, and there is no evidence of its being a therapeutic target or its involvement in disease as of current literature[2]. Key context: - The parent molecule, 7SL RNA, is essential in the signal recognition particle for protein translocation, but RN7SL96P itself is not part of the SRP or known biological complexes[3][1]. - Many pseudogenes can be transcribed and may yield regulatory short RNAs or influence epigenetic marks, though evidence for RN7SL96P's activity is currently lacking[2]. - RN7SL96P is categorized as a processed pseudogene rather than a protein-coding or structural RNA gene. If you require information about the parent functional molecule (7SL RNA or SRP RNA), it can be detailed separately, as this entry refers specifically to the pseudogene variant.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 96, pseudogene (RN7SL96P).